Atlas Venture's Quartet aims to harness the immune system to make painkillers
October 23, 2014 at 08:00 AM EDT
While one of the hottest areas of cancer drug development is based on an approach that uses the body's immune system, a handful of investors are making a $17 million bet on a Cambridge biotech aiming to take a similar approach to pain management...